| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJMRA073096 |
| P698 | PubMed publication ID | 18172175 |
| P2093 | author name string | Galila Agam | |
| R.H. Belmaker | |||
| P2860 | cites work | Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference | Q44374790 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 55-68 | |
| P577 | publication date | 2008-01-03 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Major Depressive Disorder | |
| P478 | volume | 358 |
| Q33778302 | 3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders. |
| Q48721780 | 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A. |
| Q36360531 | A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats |
| Q26866012 | A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression |
| Q34333537 | A comprehensive network and pathway analysis of candidate genes in major depressive disorder |
| Q35114644 | A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies |
| Q38596921 | A critical appraisal of the selegiline transdermal system for major depressive disorder |
| Q49340301 | A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder. |
| Q34999207 | A family with Parkinsonism, essential tremor, restless legs syndrome, and depression. |
| Q33884174 | A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy |
| Q33899136 | A molecular signature of depression in the amygdala |
| Q38164159 | A neuroscientific update on monoamine oxidase and its inhibitors |
| Q43184506 | A novel chronic social stress paradigm in female mice |
| Q35623581 | A pre-conditioning stress accelerates increases in mouse plasma inflammatory cytokines induced by stress |
| Q37174358 | A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the Pleasant Events Program (PEP) |
| Q64103217 | A reduced concentration of brain interstitial amino acids is associated with depression in subarachnoid hemorrhage patients |
| Q53407108 | A review of physiological and behavioral monitoring with digital sensors for neuropsychiatric illnesses. |
| Q92367797 | A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression |
| Q48258252 | A study of the combined effects of the EHD3 and FREM3 genes in patients with major depressive disorder |
| Q37622651 | A support vector machine model provides an accurate transcript-level-based diagnostic for major depressive disorder |
| Q42415187 | A yes or no answer |
| Q37349864 | Aberrant emotion networks in early major depressive disorder patients: an eigenvector centrality mapping study |
| Q89746084 | Abnormal resting-state functional connectivity of hippocampal subfields in patients with major depressive disorder |
| Q29042551 | Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs |
| Q30505292 | Acute D-serine treatment produces antidepressant-like effects in rodents |
| Q27322385 | Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice |
| Q35840423 | Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry |
| Q34514006 | Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling |
| Q37270921 | Adult Brain Serotonin Deficiency Causes Hyperactivity, Circadian Disruption, and Elimination of Siestas. |
| Q38783172 | Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht Study |
| Q34976388 | Alcohol intake, wine consumption and the development of depression: the PREDIMED study |
| Q28302013 | Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders |
| Q99404602 | Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function |
| Q37002871 | Alteration by p11 of mGluR5 localization regulates depression-like behaviors |
| Q35165235 | Alterations in white matter fractional anisotropy in subsyndromal perimenopausal depression |
| Q36453010 | Altered Expression of Endoplasmic Reticulum Stress Associated Genes in Hippocampus of Learned Helpless Rats: Relevance to Depression Pathophysiology |
| Q33553152 | Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression |
| Q35688931 | Altered expression of neuroplasticity-related genes in the brain of depressed suicides |
| Q48076059 | Altered functional connectivity density in major depressive disorder at rest |
| Q28473511 | Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression |
| Q48420718 | Altered sleep brain functional connectivity in acutely depressed patients |
| Q38768098 | An Increase in Plasma Homovanillic Acid with Cocoa Extract Consumption Is Associated with the Alleviation of Depressive Symptoms in Overweight or Obese Adults on an Energy Restricted Diet in a Randomized Controlled Trial. |
| Q38849487 | An Overview of the Effect of Probiotics and Exercise on Mood and Associated Health Conditions |
| Q30581172 | An affective disorder in zebrafish with mutation of the glucocorticoid receptor |
| Q53412802 | An estradiol-independent BDNF-NPY cascade is involved in the antidepressant effect of mechanical acupuncture instruments in ovariectomized rats. |
| Q35563515 | An excitatory synapse hypothesis of depression |
| Q92242987 | Analyzing the genes and pathways related to major depressive disorder via a systems biology approach |
| Q33492470 | Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies |
| Q57025363 | Anatomically Defined and Functionally Distinct Dorsal Raphe Serotonin Sub-systems |
| Q48062498 | Antidepressant Potential of Chlorogenic Acid-Enriched Extract from Eucommia ulmoides Oliver Bark with Neuron Protection and Promotion of Serotonin Release through Enhancing Synapsin I Expression. |
| Q36820104 | Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress |
| Q42726331 | Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L. |
| Q37604161 | Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence |
| Q39761679 | Antidepressant-like effect of Ilex paraguariensis in rats |
| Q47557106 | Antidepressant-like effects of Gan-Mai-Dazao-Tang via monoamine regulatory pathways on forced swimming test in rats. |
| Q35788794 | Antidepressant-like effects of methanolic extract of Bacopa monniera in mice |
| Q90427483 | Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide |
| Q91843016 | Antidepressants are modifiers of lipid bilayer properties |
| Q44889816 | Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? |
| Q37539807 | Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach |
| Q91655912 | Antidepressive potential of aqueous extract of common vervain ( V. officinalis L. Verbenaceae) and molecular docking studies of its main components as potential antidepressive agents: PS097 |
| Q50053673 | Anxiety and Mood Clinical Profile following Sport-related Concussion: From Risk Factors to Treatment. |
| Q35151755 | Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes? |
| Q90011773 | Anxiolytic and anti-depressant effects of hydroalcoholic extract from Erythrina variegata and its possible mechanism of action |
| Q37726720 | Association between depressive disorders and risk of breast cancer recurrence after curative surgery |
| Q40197496 | Association between dopamine beta-hydroxylase 19-bp insertion/deletion polymorphism and major depressive disorder |
| Q48046042 | Association between inflammatory potential of diet and risk of depression in middle-aged women: the Australian Longitudinal Study on Women's Health |
| Q35173316 | Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol. |
| Q90168362 | Association between social asymmetry and depression in older adults: A phone Call Detail Records analysis |
| Q28397648 | Association of Major Depression With Risk of Ischemic Heart Disease in a Mega-Cohort of Chinese Adults: The China Kadoorie Biobank Study |
| Q57515292 | Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank |
| Q37173473 | Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode |
| Q44020787 | Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women |
| Q36032535 | Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study |
| Q43104615 | Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis |
| Q40857521 | Associations of low grade inflammation and endothelial dysfunction with depression - The Maastricht Study. |
| Q92810734 | Associations of n-3, n-6 Fatty Acids Intakes and n-6:n-3 Ratio with the Risk of Depressive Symptoms: NHANES 2009-2016 |
| Q37062552 | Augmentation treatment in major depressive disorder: focus on aripiprazole |
| Q39298316 | BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats |
| Q38686757 | BEHAVIORAL EVIDENCE OF ANTIDEPRESSANT-LIKE ACTIVITY OF RAPHANUS SATIVUS L. VAR. CAUDATUS IN MICE. |
| Q36893717 | Behavioral and neuronal biochemical possible effects in experimental induced chronic mild stress in male albino rats under the effect of oral barley administration in comparison to venlafaxine |
| Q36450343 | Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease |
| Q30580754 | Behavioural screening of zebrafish using neuroactive traditional Chinese medicine prescriptions and biological targets |
| Q26830010 | Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders |
| Q57490780 | Bidirectional Microglia-Neuron Communication in Health and Disease |
| Q34729968 | Bidirectional association between depression and type 2 diabetes mellitus in women |
| Q33820463 | Biological substrates underpinning diagnosis of major depression |
| Q38366733 | Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses |
| Q57533247 | Bipolar disorder and adiposity: a study using whole body dual energy X-ray absorptiometry scans |
| Q34345609 | Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy. |
| Q38378351 | Bone, brain & beyond |
| Q28392759 | Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water |
| Q46544374 | Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness |
| Q30724976 | Brain network dysfunction in late-life depression: a literature review |
| Q37594329 | Brain plasticity and genetic factors |
| Q48055137 | Brain-derived Neurotrophic Factor Signaling Mediates the Antidepressant-like Effect of the Total Flavonoids of Alpiniae Oxyphyllae Fructus in Chronic Unpredictable Mild Stress Mice |
| Q34621808 | Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. |
| Q91641482 | Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience |
| Q37378006 | C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia |
| Q34381806 | Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. |
| Q26745684 | Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology |
| Q35761130 | Changes of Functional Brain Networks in Major Depressive Disorder: A Graph Theoretical Analysis of Resting-State fMRI. |
| Q37262684 | Changes of grey matter volume in first-episode drug-naive adult major depressive disorder patients with different age-onset |
| Q28513344 | Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of [...] |
| Q51802112 | Childhood and young adult overweight/obesity and incidence of depression in the SUN project. |
| Q34362227 | Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release. |
| Q42945730 | Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats. |
| Q37435620 | Cigarette smoking and completed suicide: results from 3 prospective cohorts of American adults |
| Q89747517 | Circadian rhythm disruption and mental health |
| Q45300839 | Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. |
| Q52356865 | Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders. |
| Q47814198 | Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders |
| Q64082978 | Co-expression network modeling identifies key long non-coding RNA and mRNA modules in altering molecular phenotype to develop stress-induced depression in rats |
| Q34425199 | Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults |
| Q89124647 | Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial |
| Q81104872 | Comment on: 'antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence' |
| Q34001513 | Common genes contribute to depressive symptoms and heart rate variability: the Twins Heart Study |
| Q34435376 | Community-Based Mindfulness Program for Disease Prevention and Health Promotion: Targeting Stress Reduction |
| Q26784356 | Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms |
| Q40053306 | Correlation between hormone receptor status and depressive symptoms in patients with metastatic breast cancer |
| Q37159953 | Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal |
| Q37649760 | Cortisol diurnal patterns, associations with depressive symptoms, and the impact of intervention in older adults: results using modern robust methods aimed at dealing with low power due to violations of standard assumptions |
| Q39665841 | Cortisol levels and history of depression in acute coronary syndrome patients |
| Q38188664 | D-Serine in neurobiology: CNS neurotransmission and neuromodulation. |
| Q36785486 | D-serine as a gliotransmitter and its roles in brain development and disease |
| Q38820530 | DNA Damage in Major Psychiatric Diseases |
| Q30580130 | Data-driven subtypes of major depressive disorder: a systematic review |
| Q58187895 | Decoded Neurofeedback: Eligibility, Applicability, and Reliability Issues for Use in Schizophrenia and Major Depressive Disorder |
| Q39928282 | Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment. |
| Q35844216 | Decreased neuroautonomic complexity in men during an acute major depressive episode: analysis of heart rate dynamics |
| Q85249286 | Deep brain stimulation |
| Q37444925 | Deep brain stimulation for psychiatric disorders--state of the art. |
| Q37591435 | Deep-brain magnetic stimulation promotes adult hippocampal neurogenesis and alleviates stress-related behaviors in mouse models for neuropsychiatric disorders |
| Q83159386 | Deep-brain stimulation for depression |
| Q34506637 | Delineation of early and later adult onset depression by diffusion tensor imaging |
| Q47315755 | Dendritic cell nuclear protein-1 regulates melatonin biosynthesis by binding to BMAL1 and inhibiting the transcription of N-acetyltransferase in C6 cells. |
| Q33652384 | Dendritic cell nuclear protein-1, a novel depression-related protein, upregulates corticotropin-releasing hormone expression |
| Q34125168 | Dense cranial electroacupuncture stimulation for major depressive disorder--a single-blind, randomized, controlled study |
| Q33604721 | Depression Disorder Classification of fMRI Data Using Sparse Low-Rank Functional Brain Network and Graph-Based Features |
| Q48071228 | Depression Narratives in Blogs: A Collaborative Quest for Coherence |
| Q47763896 | Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment |
| Q46957323 | Depression and cardiovascular risk factors: evidence from a large postmortem sample. |
| Q35471566 | Depression as a risk factor for overall and hormone-related cancer: the Korean cancer prevention study. |
| Q36532479 | Depression as a systemic syndrome: mapping the feedback loops of major depressive disorder |
| Q58794859 | Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism |
| Q37231121 | Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder |
| Q37971293 | Depression in Parkinson disease--epidemiology, mechanisms and management. |
| Q38227570 | Depression in pulmonary arterial hypertension and interstitial lung diseases. |
| Q41049430 | Depression is associated with increased C-reactive protein levels in patients with heart failure and hyperuricemia |
| Q33970830 | Depression overview |
| Q35838835 | Depression, Anxiety, Resilience and Coping Pre and Post Kidney Transplantation - Initial Findings from the Psychiatric Impairments in Kidney Transplantation (PI-KT)-Study |
| Q57253298 | Depression, antidepressant treatment and the cardiovascular system. |
| Q35075284 | Depression-like effect of prenatal buprenorphine exposure in rats |
| Q49112729 | Depression: interrupted genetic seesaws in the hypothalamus. |
| Q38981346 | Depressive symptoms predict future simple disease activity index scores and simple disease activity index remission in a prospective cohort of patients with early inflammatory polyarthritis |
| Q41351751 | Depressive-like behavior in mice recently recovered from motor disorders after 3-nitropropionic acid intoxication |
| Q35179010 | Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease |
| Q57097268 | Design, synthesis and evaluation of antidepressant activity of novel 2-methoxy 1, 8 naphthyridine 3-carboxamides as 5-HT3 receptor antagonists |
| Q37322241 | Desvenlafaxine extended release |
| Q37682552 | Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms |
| Q34212814 | Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: with application to major depressive disorder |
| Q35054544 | Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template. |
| Q37447228 | Diagnosis and causal explanation in psychiatry. |
| Q35547281 | Dietary fat intake and quality of life: the SUN project |
| Q33813627 | Dietary fat intake and the risk of depression: the SUN Project |
| Q45931461 | Dietary glycaemic load and odds of depression in a group of institutionalized elderly people without antidepressant treatment. |
| Q34628274 | Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study |
| Q38807396 | Dietary pattern derived by reduced rank regression and depressive symptoms in a multi-ethnic population: the HELIUS study. |
| Q104795025 | Differential and spatial expression meta-analysis of genes identified in genome-wide association studies of depression |
| Q34092650 | Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. |
| Q35604108 | Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression |
| Q35195914 | Differentially expressed genes in major depression reside on the periphery of resilient gene coexpression networks |
| Q55615001 | Diffusional kurtosis imaging and white matter microstructure modeling in a clinical study of major depressive disorder. |
| Q30416674 | Diminished appetitive startle modulation following targeted inhibition of prefrontal cortex |
| Q33699214 | Diurnal patterns and associations among salivary cortisol, DHEA and alpha-amylase in older adults. |
| Q47106135 | Dual Depression: A Sex Perspective |
| Q92698941 | Dual Role of Autophagy in Diseases of the Central Nervous System |
| Q48385750 | Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. |
| Q52650242 | Early Life Stress, Depression And Parkinson's Disease: A New Approach. |
| Q44425348 | Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain |
| Q92381430 | Effect of adjunct yoga therapy in depressive disorders: Findings from a randomized controlled study |
| Q48512233 | Effects of Endurance Exercise Modalities on Arterial Stiffness in Patients Suffering from Unipolar Depression: A Randomized Controlled Trial. |
| Q42517534 | Effects of Hint1 deficiency on emotional-like behaviors in mice under chronic immobilization stress. |
| Q48346007 | Effects of Kaixin Jieyu Decoction () on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model |
| Q47792740 | Effects of Refined Xiaoyaosan on Depressive-Like Behaviors in Rats with Chronic Unpredictable Mild Stress through Neurosteroids, Their Synthesis and Metabolic Enzymes |
| Q42773355 | Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity |
| Q47423746 | Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration. |
| Q37480053 | Effects of estradiol on learned helplessness and associated remodeling of hippocampal spine synapses in female rats. |
| Q48238506 | Effects of kaixin jieyu decoction on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model |
| Q59807356 | Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis |
| Q91459492 | Efficacy of trial-based cognitive therapy, behavioral activation and treatment as usual in the treatment of major depressive disorder: preliminary findings from a randomized clinical trial |
| Q34039560 | Efficacy of vitamin D supplementation in depression in adults: a systematic review |
| Q37676861 | Electroconvulsive therapy and nursing care |
| Q47368013 | Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment |
| Q92081703 | Elucidation of the Molecular Mechanism Underlying Lippia citriodora(Lim.)-Induced Relaxation and Anti-Depression |
| Q46960252 | Embryonic exposure to corticosterone modifies aggressive behavior through alterations of the hypothalamic pituitary adrenal axis and the serotonergic system in the chicken |
| Q43473758 | Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study |
| Q30468912 | Enhanced auditory brainstem response and parental bonding style in children with gastrointestinal symptoms |
| Q46611419 | Enriched Flavonoid Fraction from Cecropia pachystachya Trécul Leaves Exerts Antidepressant-like Behavior and Protects Brain Against Oxidative Stress in Rats Subjected to Chronic Mild Stress |
| Q36213137 | Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression |
| Q64076067 | Epigenetic Regulations in Neuropsychiatric Disorders |
| Q34426216 | Epigenetic alterations in depression and antidepressant treatment |
| Q34479047 | Epigenetic and genetic factors predict women's salivary cortisol following a threat to the social self |
| Q37061840 | Epigenetic differences in monozygotic twins discordant for major depressive disorder |
| Q37249121 | Epigenetics and psychiatry |
| Q92618208 | Epinephrine increases malignancy of breast cancer through p38 MAPK signaling pathway in depressive disorders |
| Q34417778 | ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder |
| Q48232589 | Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients |
| Q37938732 | Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression |
| Q43042970 | Escitalopram in the treatment of major depressive disorder in adolescent patients. Profile report |
| Q37756111 | Escitalopram: in the treatment of major depressive disorder in adolescent patients |
| Q39103844 | Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine |
| Q37753320 | Estrogen in the limbic system |
| Q48075886 | Etiological heterogeneity of symptom dimensions of adolescent depression |
| Q34239214 | Evolutionary theories of depression: a critical review |
| Q33980290 | Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics |
| Q90312891 | Examining the underpinnings of loudness dependence of auditory evoked potentials with positron emission tomography |
| Q47649037 | Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts |
| Q41576968 | Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression |
| Q92016927 | Far-infrared Ray-mediated Antioxidant Potentials are Important for Attenuating Psychotoxic Disorders |
| Q41967620 | Fear erasure in mice requires synergy between antidepressant drugs and extinction training. |
| Q93078155 | Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex |
| Q42292947 | Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment |
| Q38300372 | Food for thought: understanding the value, variety and usage of management algorithms for major depressive disorder |
| Q38742846 | Food patterns and the prevention of depression. |
| Q35027670 | Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene |
| Q27316024 | Gamma oscillation in functional brain networks is involved in the spontaneous remission of depressive behavior induced by chronic restraint stress in mice |
| Q58152649 | Gata1 overexpression in neurons increases the expression of cell-mediated cytotoxicity-related genes |
| Q40904308 | Gene expression in major depressive disorder |
| Q58786918 | Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP) |
| Q34765123 | Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology |
| Q37847575 | Genetics of depression: an overview of the current science |
| Q28265155 | Genetics of smoking and depression |
| Q57323019 | Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts |
| Q58765611 | Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression |
| Q24610225 | Getting the balance right: Established and emerging therapies for major depressive disorders |
| Q35193396 | Glutamate and lipid metabolic perturbation in the hippocampi of asymptomatic borna disease virus-infected horses |
| Q24653626 | Glutamate and neurotrophic factors in neuronal plasticity and disease |
| Q91951348 | Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD |
| Q48506951 | Green tea and coffee consumption is inversely associated with depressive symptoms in a Japanese working population. |
| Q91794756 | Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression |
| Q90268441 | HMGB1 involved in stress-induced depression and its neuroinflammatory priming role: a systematic review |
| Q35149929 | Harnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders |
| Q26786225 | Herbal Medicine for Anxiety, Depression and Insomnia |
| Q35592683 | High dimensional endophenotype ranking in the search for major depression risk genes |
| Q41728509 | Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression |
| Q48223579 | Hippocampal GSK3β as a Molecular Link Between Obesity and Depression. |
| Q36634037 | Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis |
| Q47273663 | Hippocampal extracellular matrix alterations contribute to cognitive impairment associated with a chronic depressive-like state in rats. |
| Q35591334 | How do psychiatric drugs work? |
| Q30671322 | IL-4/10 prevents stress vulnerability following imipramine discontinuation |
| Q36508139 | Identification and validation of urinary metabolite biomarkers for major depressive disorder |
| Q48043110 | Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder |
| Q100737261 | Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography |
| Q33762512 | Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways |
| Q34550430 | Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review |
| Q33817916 | Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women |
| Q89121883 | Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers) |
| Q36398172 | Impact on behavioral changes due to chronic use of sertraline in Wistar albino rats |
| Q35965584 | Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report |
| Q38785648 | Increase in the prescription rate of antidepressants after the Sewol Ferry disaster in Ansan, South Korea |
| Q48889004 | Increased hippocampal tau phosphorylation and axonal mitochondrial transport in a mouse model of chronic stress. |
| Q34848679 | Increased mortality risk in women with depression and diabetes mellitus |
| Q36736022 | Increased oxidative stress in patients with depression and its relationship to treatment |
| Q36162021 | Increasing Pain Sensation Eliminates the Inhibitory Effect of Depression on Evoked Pain in Rats |
| Q34299338 | Inflammasomes in neuroinflammation and changes in brain function: a focused review |
| Q97519980 | Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis |
| Q37625898 | Inflammatory dietary pattern and risk of depression among women |
| Q50786215 | Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. |
| Q48684627 | Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. |
| Q39034597 | Influence of genetic polymorphisms involved in the hypothalamic-pituitary-adrenal axis and their interactions with environmental factors on antidepressant response. |
| Q59328950 | Inhibition of GALR1 in PFC Alleviates Depressive-Like Behaviors in Postpartum Depression Rat Model by Upregulating CREB-BNDF and 5-HT Levels |
| Q35806777 | Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders. |
| Q42246232 | Interleukin-10: a key cytokine in depression? |
| Q64107926 | Intracerebroventricular Ghrelin Administration Increases Depressive-Like Behavior in Male Juvenile Rats |
| Q41979813 | Intranasal delivery of a peptide with antidepressant-like effect |
| Q39430810 | Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder |
| Q92478501 | Is There a Role of Autophagy in Depression and Antidepressant Action? |
| Q38849673 | Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease? |
| Q26747511 | Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder |
| Q35073131 | Is there an association between symptoms of anxiety and depression and quality of life in patients with chronic obstructive pulmonary disease? |
| Q49691620 | Ketamine-induced prefrontal serotonin release is mediated by cholinergic neurons in the pedunculopontine tegmental nucleus. |
| Q47623195 | Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice |
| Q92913293 | L-menthol exhibits antidepressive-like effects mediated by the modification of 5-HTergic, GABAergic and DAergic systems |
| Q48348353 | Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression |
| Q27308130 | Laminar and cellular analyses of reduced somatostatin gene expression in the subgenual anterior cingulate cortex in major depression |
| Q98177904 | Lavender Oil Reduces Depressive Mood in Healthy Individuals and Enhances the Activity of Single Oxytocin Neurons of the Hypothalamus Isolated from Mice: A Preliminary Study |
| Q30410489 | Learning and memory ... and the immune system |
| Q37189718 | Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants |
| Q38255663 | Levomilnacipran extended-release: a review of its use in adult patients with major depressive disorder |
| Q38099044 | Lifestyle management of unipolar depression |
| Q57157635 | Linking unfolded protein response to inflammation and depression: potential pathologic and therapeutic implications |
| Q28478124 | Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients |
| Q36801188 | Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression |
| Q43790136 | Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine |
| Q40676232 | MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders |
| Q28727310 | MK4MDD: a multi-level knowledge base and analysis platform for major depressive disorder |
| Q36167638 | Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise |
| Q44270360 | Magnesium intake is not related to depression risk in Spanish university graduates |
| Q39340736 | Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies |
| Q58097916 | Manipulation of dorsal raphe serotonergic neurons modulates active coping to inescapable stress and anxiety-related behaviors in mice and rats |
| Q37742091 | Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy |
| Q57130776 | Maternal parity and perinatal cortisol adaptation: The role of pregnancy-specific distress and implications for postpartum mood |
| Q34034642 | Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: results from a large community-based prospective study |
| Q36291647 | Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression |
| Q46327960 | Methylene blue and its analogues as antidepressant compounds. |
| Q55365457 | MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment. |
| Q37368965 | MicroRNAs in mental health: from biological underpinnings to potential therapies |
| Q30982409 | Microarray Analysis of the Major Depressive Disorder mRNA Profile Data |
| Q41699494 | Microglia: An Interface between the Loss of Neuroplasticity and Depression |
| Q38817194 | Microtubule and microtubule associated protein anomalies in psychiatric disease |
| Q34001184 | Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain? |
| Q79774804 | Mitochondrial dysfunction and psychiatric disorders |
| Q34361887 | Modeling the dynamics of disease states in depression. |
| Q28084163 | Modeling the hypothalamus-pituitary-adrenal axis: A review and extension |
| Q57490409 | Modulatory interactions of resting-state brain functional connectivity in major depressive disorder |
| Q47396901 | Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant |
| Q36755164 | Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders |
| Q27345087 | Molecular and Genetic Characterization of Depression: Overlap with other Psychiatric Disorders and Aging |
| Q37198752 | Molecular epidemiology of major depressive disorder |
| Q54972216 | Monoamines differentially modulate neuropeptide release from distinct sites within a single neuron pair. |
| Q43257873 | Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression |
| Q26862798 | Mood disorders: A potential link between ghrelin and leptin on human body? |
| Q34114364 | Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder |
| Q55248869 | Multivariate Classification of Major Depressive Disorder Using the Effective Connectivity and Functional Connectivity. |
| Q47744128 | NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction. |
| Q92993515 | NMDA receptors and L-arginine/nitric oxide/cyclic guanosine monophosphate pathway contribute to the antidepressant-like effect of Yueju pill in mice |
| Q37672956 | Near-Infrared Spectroscopy Reveals Abnormal Hemodynamics in the Left Dorsolateral Prefrontal Cortex of Menopausal Depression Patients. |
| Q48173016 | Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat. |
| Q48054616 | Neural effects of social environmental stress - an activation likelihood estimation meta-analysis |
| Q89684509 | Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression |
| Q39717355 | Neuroanatomic pathways associated with monoaminergic dysregulation after stroke. |
| Q37864290 | Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. |
| Q39117248 | Neurobiology of depression: A neurodevelopmental approach |
| Q51738419 | Neuroimaging genomic studies in major depressive disorder: A systematic review. |
| Q90520292 | Neuroinflammation, Gut-Brain Axis and Depression |
| Q64969956 | Neuronal nitric oxide synthase and affective disorders. |
| Q64910410 | Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. |
| Q37581584 | Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression |
| Q35048215 | Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence |
| Q84724644 | Neurotransmitters, receptors, and second messengers galore in 40 years |
| Q26999061 | Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence |
| Q38007130 | New perspectives on glutamate receptor antagonists as antidepressants. |
| Q34984422 | No association between a polymorphism of the adenylate cyclase type IX gene and major depressive disorder in the Chinese Han population |
| Q28751388 | Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies |
| Q36327782 | Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression |
| Q38984077 | Oxidative Stress and the Central Nervous System |
| Q37661360 | Oxidative stress and psychological disorders |
| Q92135344 | P11 Loss-of-Function is Associated with Decreased Cell Proliferation and Neurobehavioral Disorders in Mice |
| Q50955574 | Palladium-catalyzed oxidative 6-exo-trig cyclization of 1,6-enynes: facile synthesis of bicyclo[4.1.0]heptan-5-ones. |
| Q36890229 | Parkinson's disease-related fatigue: A case definition and recommendations for clinical research |
| Q37855006 | Pathogen burden and cortisol profiles over the day. |
| Q35956471 | Pathogenetic and therapeutic applications of microRNAs in major depressive disorder |
| Q34145754 | Pathophysiology of depression: do we have any solid evidence of interest to clinicians? |
| Q40523595 | Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study |
| Q41017682 | Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study |
| Q37176590 | Peripheral biomarkers in animal models of major depressive disorder |
| Q48220933 | Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression |
| Q113506350 | Personalized machine learning of depressed mood using wearables |
| Q37329171 | Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety |
| Q43153851 | Phytotherapy of experimental depression: Kalanchoe integra Var. Crenata (Andr.) Cuf Leaf Extract |
| Q48136147 | Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity |
| Q48130319 | Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors. |
| Q48179516 | Plasma galanin is a biomarker for severity of major depressive disorder. |
| Q46248790 | Plasma sphingolipids and depressive symptoms in coronary artery disease |
| Q48168936 | Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice |
| Q35432034 | Postnatal loss of hap1 reduces hippocampal neurogenesis and causes adult depressive-like behavior in mice |
| Q35207266 | Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke |
| Q38101167 | Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery |
| Q24657796 | Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders |
| Q36273251 | Pregnancy Hyperglycaemia and Risk of Prenatal and Postpartum Depressive Symptoms. |
| Q37015586 | Prevalence of anxiety and depressive symptoms among patients with hypothyroidism |
| Q33873674 | Prioritization and evaluation of depression candidate genes by combining multidimensional data resources |
| Q45910793 | Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: longitudinal 1H-MR spectroscopy study. |
| Q91345109 | Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis |
| Q94599687 | Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder |
| Q57169146 | Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future |
| Q38885740 | Psychiatric disorders biochemical pathways unraveled by human brain proteomics |
| Q37157851 | Psychiatric research: psychoproteomics, degradomics and systems biology |
| Q48594178 | Psycho-physical and neurophysiological effects of qigong on depressed elders with chronic illness. |
| Q37644244 | Psychosomatic aspects of Cushing's syndrome |
| Q36871302 | Psychotropic drugs: implications for dental practice |
| Q47426476 | Quantitative proteomic study of the plasma reveals acute phase response and LXR/RXR and FXR/RXR activation in the chronic unpredictable mild stress mouse model of depression |
| Q47867484 | Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex. |
| Q38285502 | Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression. |
| Q33707696 | Rare damaging variants in DNA repair and cell cycle pathways are associated with hippocampal and cognitive dysfunction: a combined genetic imaging study in first-episode treatment-naive patients with schizophrenia |
| Q88907581 | Recognizing Depression from the Microbiota⁻Gut⁻Brain Axis |
| Q37934335 | Reconsidering GHB: orphan drug or new model antidepressant? |
| Q44565588 | Recurrent long-lasting tethering reduces BDNF protein levels in the dorsal hippocampus and frontal cortex in pigs. |
| Q37167833 | Recurrent major depression and right hippocampal volume: A bivariate linkage and association study |
| Q35113802 | Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder |
| Q38371329 | Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases |
| Q27027115 | Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders |
| Q47565260 | Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study. |
| Q48051184 | Relationship between adherence to Dietary Approaches to Stop Hypertension (DASH) diet indices and incidence of depression during up to 8 years of follow-up |
| Q48122641 | Relationship between depressive symptoms and hypogonadism in men with COPD. |
| Q44713785 | Religiousness, religious coping methods and distress level among psychiatric patients in Malaysia |
| Q37365049 | Repeated acupuncture treatments modulate amygdala resting state functional connectivity of depressive patients. |
| Q35166909 | Residents' perceptions of their own sadness--a qualitative study in Norwegian nursing homes |
| Q48273114 | Restraint stress differentially regulates inflammation and glutamate receptor gene expression in the hippocampus of C57BL/6 and BALB/c mice. |
| Q93118079 | Reward and avoidance learning in the context of aversive environments and possible implications for depressive symptoms |
| Q35883903 | Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effects in a Mouse Model of Depression |
| Q34804033 | Right and left amygdalae activation in patients with major depression receiving antidepressant treatment, as revealed by fMRI. |
| Q47616236 | Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study |
| Q52594126 | Risk of hip fractures in patients with depressive disorders: A nationwide, population-based, retrospective, cohort study. |
| Q36123988 | Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory |
| Q91938335 | Role of Corticotropin Releasing Factor in the Neuroimmune Mechanisms of Depression: Examination of Current Pharmaceutical and Herbal Therapies |
| Q40010904 | Role of Serum Brain Derived Neurotrophic Factor and Central N-Acetylaspartate for Clinical Response under Antidepressive Pharmacotherapy |
| Q92970043 | Role of Tryptophan in Microbiota-Induced Depressive-Like Behavior: Evidence From Tryptophan Depletion Study |
| Q37858641 | Role of brain orexin in the pathophysiology of functional gastrointestinal disorders. |
| Q37254797 | Role of endocannabinoid signaling in anxiety and depression |
| Q37275625 | Role of orexin in central regulation of gastrointestinal functions |
| Q28295413 | SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity |
| Q35219833 | Sadness: diagnosis, evaluation, and treatment |
| Q59795760 | Scrub typhus and depression: a nationwide cohort analysis |
| Q38568670 | Secreted frizzled-related protein 3 (sFRP3) regulates antidepressant responses in mice and humans |
| Q90381600 | Selecting an Appropriate Animal Model of Depression |
| Q24632508 | Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders |
| Q36393251 | Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication. |
| Q35161420 | Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression. |
| Q47664087 | Serum Concentrations of 25-Hydroxyvitamin D and Depression in a General Middle-Aged to Elderly Population in Finland. |
| Q48083842 | Serum Levels of High-sensitivity C-Reactive Protein at Admission Are More Strongly Associated with Poststroke Depression in Acute Ischemic Stroke than Homocysteine Levels |
| Q47965705 | Serum levels of homocysteine at admission are associated with post-stroke depression in acute ischemic stroke |
| Q37347574 | Serum proteomic profiling of major depressive disorder |
| Q58712292 | Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202 |
| Q30409984 | Sex chromosome complement regulates expression of mood-related genes. |
| Q52665670 | Sex differences in gut microbiota in patients with major depressive disorder. |
| Q34721416 | Sex differences in mood disorders: perspectives from humans and rodent models |
| Q33833663 | Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse (Peromyscus californicus). |
| Q37263329 | Sex-related factors influence expression of mood-related genes in the basolateral amygdala differentially depending on age and stress exposure. |
| Q42491063 | Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle. |
| Q35692566 | Simultaneous Decomposition of Depression Heterogeneity on the Person-, Symptom- and Time-Level: The Use of Three-Mode Principal Component Analysis |
| Q83227660 | Single-cell transcriptomes and whole-brain projections of serotonin neurons in the mouse dorsal and median raphe nuclei |
| Q64082286 | Skin conductance responses in Major Depressive Disorder (MDD) under mental arithmetic stress |
| Q28510280 | Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities |
| Q33940576 | Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress |
| Q35163769 | Somatostatin, neuronal vulnerability and behavioral emotionality |
| Q48378313 | Stable modifications to the expression of neurohormones in the rat hypothalamus in a model of post-traumatic stress disorder |
| Q36950782 | Strategies for improving cardiovascular health in women with diabetes mellitus: a review of the evidence |
| Q90606771 | Stress vulnerability promotes an alcohol-prone phenotype in a preclinical model of sustained depression |
| Q37923498 | Stress, glucocorticoids and liquorice in human pregnancy: programmers of the offspring brain |
| Q36665088 | Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior |
| Q90164396 | Sub-regional anterior cingulate cortex functional connectivity revealed default network subsystem dysfunction in patients with major depressive disorder |
| Q34158919 | Subcortical biophysical abnormalities in patients with mood disorders |
| Q50252819 | Suicidal drug overdose following stroke in elderly patients: a retrospective population-based cohort study. |
| Q47616784 | Sustained Molecular Pathology Across Episodes and Remission in Major Depressive Disorder |
| Q37636702 | Synchrony of diurnal cortisol pattern in couples |
| Q38178158 | Systematic review of gamma-aminobutyric-acid inhibitory deficits across the reproductive life cycle |
| Q31128463 | Systems biology integration of proteomic data in rodent models of depression reveals involvement of the immune response and glutamatergic signaling |
| Q93103257 | TDAG51 is a crucial regulator of maternal care and depressive-like behavior after parturition |
| Q35742891 | Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants |
| Q38346170 | Tea consumption and the risk of depression: a meta-analysis of observational studies |
| Q48967970 | Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. |
| Q38128398 | Telomeres and endocrine dysfunction of the adrenal and GH/IGF-1 axes |
| Q39311431 | Temporal profiling of depression vulnerability in a preclinical model of sustained depression. |
| Q47805738 | Th17 cells in depression. |
| Q33706833 | The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior |
| Q37538381 | The 5-HT1A receptor in Major Depressive Disorder |
| Q51739456 | The 5-HT1B receptor - a potential target for antidepressant treatment. |
| Q33738349 | The 5-HT7 receptor and disorders of the nervous system: an overview |
| Q50072182 | The Antidepressant Effect of Light Therapy from Retinal Projections. |
| Q57515406 | The Association Between Depression and Heart Disease: The Role of Genetic Factors |
| Q35683649 | The C825T Polymorphism of the G-Protein β3 Gene as a Risk Factor for Depression: A Meta-Analysis |
| Q47852468 | The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings |
| Q26738415 | The Co-evolution of Neuroimaging and Psychiatric Neurosurgery |
| Q58267824 | The Complexity of Deep Brain Stimulation and Suicidality in Patients with Treatment Resistant Depression |
| Q35808267 | The Effect of Fetal and Childhood Growth over Depression in Early Adulthood in a Southern Brazilian Birth Cohort |
| Q41286620 | The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence |
| Q33664080 | The Impact of Residual Symptoms in Major Depression |
| Q55137278 | The Influence of Myelin Oligodendrocyte Glycoprotein on White Matter Abnormalities in Different Onset Age of Drug-Naïve Depression. |
| Q64076382 | The Interaction of TPH2 and 5-HT2A Polymorphisms on Major Depressive Disorder Susceptibility in a Chinese Han Population: A Case-Control Study |
| Q61815592 | The Link between Thyroid Autoimmunity, Depression and Bipolar Disorder |
| Q92025076 | The Relationship between Depressive Symptoms and Modifiable Lifestyle Risk Factors in Office Workers |
| Q36546249 | The age-by-disease interaction hypothesis of late-life depression. |
| Q35371943 | The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo. |
| Q37426294 | The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction |
| Q36141436 | The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood--a prospective cohort study |
| Q39664224 | The contribution of BDNF and 5-HTT polymorphisms and early life stress to the heterogeneity of major depressive disorder: a preliminary study |
| Q38285544 | The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression |
| Q55055119 | The depression market. |
| Q92353023 | The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression |
| Q21132285 | The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats |
| Q30494370 | The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions |
| Q28290919 | The future of depression psychopharmacology |
| Q33377037 | The genetic liability to disability retirement: a 30-year follow-up study of 24,000 Finnish twins |
| Q35929482 | The heritability of postpartum depression |
| Q47878353 | The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study |
| Q35090223 | The importance of norepinephrine in depression |
| Q85944245 | The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test |
| Q34650892 | The kappa opioid receptor: from addiction to depression, and back. |
| Q43232499 | The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms |
| Q28289347 | The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential |
| Q36288255 | The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder |
| Q34644369 | The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. |
| Q48081326 | The relationship between high-sensitivity C-reactive protein at admission and post stroke depression: a 6-month follow-up study |
| Q39477318 | The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function |
| Q37729843 | The role of BDNF in depression on the basis of its location in the neural circuitry |
| Q47766376 | The role of cadherin genes in five major psychiatric disorders: A literature update. |
| Q37624460 | The role of ceramide in major depressive disorder |
| Q38032968 | The role of glia in late-life depression. |
| Q43010674 | The role of microglia in mediating the effect of the environment in brain plasticity and behavior. |
| Q26851982 | The role of orexin in post-stroke inflammation, cognitive decline, and depression |
| Q33635626 | The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment |
| Q44498877 | The stress of work, with bonus vaudeville section |
| Q38552025 | Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration |
| Q36579258 | Timosaponin derivative YY-23 acts as a non-competitive NMDA receptor antagonist and exerts a rapid antidepressant-like effect in mice |
| Q24634006 | To use or not to use: an update on licit and illicit ketamine use |
| Q55006654 | Towards characterizing the regional cerebral perfusion in evaluating the severity of major depression disorder with SPECT/CT. |
| Q37668029 | Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants |
| Q48442764 | Transient neural activation in human amygdala involved in aversive conditioning of face and voice. |
| Q26742053 | Transporting mitochondria in neurons |
| Q37397712 | Trauma, dream, and psychic change in psychoanalyses: a dialog between psychoanalysis and the neurosciences |
| Q35662230 | Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive Gαi/o Activation in Astroglial Cells |
| Q37158450 | Triple reuptake inhibitors as potential next-generation antidepressants: a new hope? |
| Q21245293 | Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile |
| Q50136497 | Unfolded protein response and associated alterations in toll-like receptor expression and interaction in the hippocampus of restraint rats. |
| Q93217452 | Updated review of research on the gut microbiota and their relation to depression in animals and human beings |
| Q46711723 | Upregulated mRNA levels of SERT, NET, MAOB, and BDNF in various brain regions of ovariectomized rats exposed to chronic aversive stimuli |
| Q57155162 | Urinary biomarker panel for diagnosing patients with depression and anxiety disorders |
| Q34631395 | Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults |
| Q33436079 | Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine |
| Q34442321 | Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release |
| Q46487037 | Utilization of Diurnal Rodents in the Research of Depression |
| Q90429698 | Vaccinium bracteatum Leaf Extract Reverses Chronic Restraint Stress-Induced Depression-Like Behavior in Mice: Regulation of Hypothalamic-Pituitary-Adrenal Axis, Serotonin Turnover Systems, and ERK/Akt Phosphorylation |
| Q89939344 | Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population |
| Q94321883 | Vilazodone for major depressive disorder in adults |
| Q40356268 | Vitamin B12, homocysteine and depressive symptoms: a longitudinal study among older adults |
| Q34178426 | Vitamin D and the occurrence of depression: causal association or circumstantial evidence? |
| Q47275480 | Weather conditions: a neglected factor in human salivary cortisol research? |
| Q47571501 | What is stressful for females? Differential effects of unpredictable environmental or social stress in CD1 female mice |
| Q34293851 | Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states |
| Q34216839 | Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings |
| Q84079155 | [Children's Depression Rating Scale-Revised (CDRS-R): development of a German version and psychometric properties in a clinical sample] |
| Q86707800 | [Clinical Applications of Peripheral Markers of Response in Antidepressant Treatment: Neurotrophins and Cytokines] |
| Q37601789 | p11 and its role in depression and therapeutic responses to antidepressants |
| Q34295208 | α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy |
| Q38241706 | ω-3 and major depression: a review |
Search more.